

TESAMORELIN 5 MG INJECTION
Drug Class: Growth Hormone-Releasing Hormone (GHRH)
Composition:
- Active Substance: Tesamorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Peptide Hubs
Tesamorelin 5 mg is a potent growth hormone-releasing hormone (GHRH) analog manufactured by Peptide Hubs. Designed for advanced research applications, this peptide is known for its ability to stimulate endogenous GH secretion and aid in fat metabolism, particularly visceral fat reduction.
Tesamorelin is a synthetic analog of GHRH with an extended half-life. It has been clinically studied for reducing abdominal fat in HIV-associated lipodystrophy and is now widely researched in the bodybuilding and longevity communities. According to this NIH-supported clinical study, Tesamorelin significantly reduced visceral adipose tissue in treated individuals.
Tesamorelin is typically reconstituted with bacteriostatic water and administered via subcutaneous injection. Research protocols commonly dose it at 1 mg per day, but variations exist depending on the experimental model. Always store vials in a refrigerated environment once reconstituted.
For broader performance or anti-aging research, Tesamorelin is often studied alongside peptides such as:
This research-grade peptide is part of a reliable peptide lineup trusted by laboratories worldwide. Backed by rigorous quality standards, Peptide Hubs ensures purity and accurate dosing in every vial.
Tesamorelin is researched for its ability to stimulate growth hormone release and reduce visceral fat, particularly in anti-aging and metabolic studies.
In research contexts, Tesamorelin is commonly dosed at 1 mg per day via subcutaneous injection, though dosing protocols may vary.
No, this peptide is strictly for research purposes only and not for human or veterinary use.
Please log in to write Tesamorelin 5 mg review.
PENTADECAPEPTIDE 2 MG INJECTION
Drug Class: Healing/Repair Peptide
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
TIRZE-PEP 5 MG INJECTION
Drug Class:Β Dual GLP-1/GIP Peptide
Composition:
- Active Substance: Tirzepatide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report